Abituzumab for the treatment of colorectal cancer
US-12171829-B2 · Dec 24, 2024 · US
This page is not indexed by search engines while we improve data quality.
Celik Ilhan patents
Celik Ilhan is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Celik Ilhan |
| Total patents | 8 |
| First publication | May 16, 2019 |
| Latest publication | Dec 24, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Compounds for the treatment of glioblastoma
US-2024277711-A1 · Aug 22, 2024 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-12054549-B2 · Aug 6, 2024 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-2023322934-A1 · Oct 12, 2023 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-11485786-B2 · Nov 1, 2022 · US
Abituzumab for the treatment of colorectal cancer
US-2020121788-A1 · Apr 23, 2020 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-2020002424-A1 · Jan 2, 2020 · US
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders
US-2019144547-A1 · May 16, 2019 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merck Patent Gmbh | 8 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 8 |
| A61K45/06 | 8 |
| C07K16/2848 | 7 |
| C07K2317/24 | 7 |
| A61K2039/505 | 7 |